ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,735Hybrid

Pharmacoeconomics

Acronym:peca
•
Abbreviation (ISO):PHARMACOECONOMICS
•
Identifier (ISSN):1170-7690(Print)/1179-2027(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
4.7↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmacoeconomics

WoS Q1
24573.9920183.7120193.5620204.9820214.5620224.420234.420244.620254.72026
Annual Impact Factor Metric
Current (2026):4.7
Scopus SJR & RankScopus Q1
1.807
#1,735

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
127

127 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate9.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
108articles/year
70.85% Gold OA•72.94% Original Research

Aims & Scope

PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes. An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker. PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization. PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.

Topics Covered (Recognized by AI)
Medicine98.3%Pathology87.1%Economics85.5%Political science76.7%Nursing76.7%Law76.7%Biology72%Public health70.4%Economic growth69.8%Health care68.9%Health economics64%Business55.7%Internal medicine54.6%Mathematics47.6%Statistics42%Psychology39.6%Health administration38.1%Engineering37.9%Management35.6%Quality of Life Research34.5%Intensive care medicine33.8%Microeconomics32.8%Risk analysis (engineering)32.1%Operations management29.3%Cost effectiveness27.7%Psychiatry27.6%Computer science25.9%Chemistry25.5%Genetics24.3%Biochemistry22.6%Surgery22.3%Environmental health21.9%Ecology21.5%Sociology20.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSSCI2026

ECONOMICS

Q1
Rank62/626
IndexSSCI
JCRSCIE2026

HEALTH CARE SCIENCES & SERVICES

Q1
Rank29/194
IndexSCIE
JCRSSCI2026

HEALTH POLICY & SERVICES

Q1
Rank9/125
IndexSSCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank78/356
IndexSCIE
JCISSCI2026

ECONOMICS

Q1
Rank81/627
IndexSSCI
JCISCIE2026

HEALTH CARE SCIENCES & SERVICES

Q1
Rank24/194
IndexSCIE
JCISSCI2026

HEALTH POLICY & SERVICES

Q1
Rank10/125
IndexSSCI
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank44/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.7
Articles / Year88
Total Citations30
2025
IF4.6
Articles / Year110
Total Citations335
2024
IF4.4
Articles / Year122
Total Citations816
2023
IF4.4
Articles / Year111
Total Citations1,763
2022
IF4.558
Articles / Year106
Total Citations2,447

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,735Scopus Q1SCImago Profile
Scopus Coverage:1992-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.807

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,623 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,637
3-Year Documents326
Citable Documents291

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate45.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health PolicyQ1
PharmacologyQ1
Public Health, Environmental and Occupational HealthQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 9.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ECONOMICS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmacoeconomics (acronym: peca, abbr: PHARMACOECONOMICS, ISSN: 1170-7690) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in New Zealand since 1992. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.807 (Q1), an H-index of 127.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 108 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,623 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Monthly
Founding Year
1992
Indexing & Databases
SCIESSCIScopusPubMed
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 9dc88354-cbfd-4504-8cb9-c79f3b5ca680
Database Updated: 2026-10-01